Franklin Templeton Investments Corp. today announced the proposed merger of Franklin World Health Sciences and Biotech Fund, Franklin World Health Sciences and Biotech Corporate Class and Franklin Technology Corporate Class into the Franklin Flex Cap Growth Corporate Class.

The merger of the four funds will help to minimize duplication within the funds as well as reduce expenses that will benefit security holders by allocating operational costs across larger portfolios.

The proposed merger will be voted on at a special meeting of security holders on August 17 in Toronto.

The proposed merger will take effect on or around August 24. The merger is subject to both security holder and regulatory approval.